DIARRHEA INCIDENCE IN MULTIPLE MYELOMA PATIENTS TREATED WITH LENALIDOMIDE AND POMALIDOMIDE

被引:0
|
作者
Capecchi, M. [1 ]
Corradini, P. [1 ]
Montefusco, V. [1 ]
机构
[1] Ist Nazl Tumori, Ematol Trapianto Midollo Osseo, Milan, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PB1983
引用
收藏
页码:795 / 796
页数:2
相关论文
共 50 条
  • [41] Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
    Short, K. Detweiler
    Rajkumar, S. V.
    Larson, D.
    Buadi, F.
    Hayman, S.
    Dispenzieri, A.
    Gertz, M.
    Kumar, S.
    Mikhael, J.
    Roy, V.
    Kyle, R. A.
    Lacy, M. Q.
    LEUKEMIA, 2011, 25 (06) : 906 - 908
  • [42] Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM).
    Ailawadhi, Sikander
    McCarthy, Philip L.
    Holstein, Sarah A.
    Larkins, Gail
    Chung, Weiyuan
    Srinivasan, Shankar
    Agarwal, Amit
    Lonial, Sagar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [43] A Multicenter Open Label Phase II Study of Pomalidomide, Cyclophosphamide and Dexamethasone in Relapse Multiple Myeloma Patients Initially Treated with Lenalidomide, Bortezomib and Dexamethasone
    Garderet, Laurent
    Kuhnowski, Frederique
    Mary, Jean Yves
    Roussel, Murielle
    Escoffre-Barbe, Martine
    Lafon, Ingrid
    Facon, Thierry
    Karlin, Lionel
    Perrot, Aurore
    Moreau, Philippe
    Marit, Gerald
    Stoppa, Anne-Marie
    Marolleau, Jean-Pierre
    Chaleteix, Carine
    Tiab, Mourad
    Araujo, Carla
    Lenain, Pascal
    Macro, Margaret
    Voog, Eric
    Benboubker, Lofti
    Allangba, Olivier
    Jourdan, Eric
    Mohty, Mohamad
    Loiseau, Herve Avet
    Mathiot, Claire
    Attal, Michel
    BLOOD, 2017, 130
  • [44] Impact of last lenalidomide dose, duration, and IMiD-free interval in patients with myeloma treated with pomalidomide/dexamethasone
    Kastritis, Efstathios
    Roussou, Maria
    Gavriatopoulou, Maria
    Kanellias, Nikolaos
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Ziogas, Dimitrios C.
    Fotiou, Despina
    Ntanasis-Stathopoulos, Ioannis
    Dialoupi, Ioanna
    Giannouli, Stavroula
    Tsirigotis, Panagiotis
    Delimpasi, Sossana
    Mparmparousi, Despina
    Spyropoulou-Vlachou, Mairylin
    Xirokosta, Aikaterini
    Terpos, Evangelos
    Dimopoulos, Meletios A.
    BLOOD ADVANCES, 2019, 3 (23) : 4095 - 4103
  • [45] Efficacy and Safety of Pomalidomide As a Replacement Therapy for Lenalidomide for Relapsed/Refractory Multiple Myeloma Patients Refractory to a Lenalidomide-Containing Combination Regimen
    Berenson, James R.
    Cohen, Alexa
    Spektor, Tanya M.
    Lashkari, Ashkan
    Mackintosh, Roy
    Bessudo, Alberto
    Jhangiani, Haresh
    Gabrail, Nashat
    Nakhoul, Ibrahim
    Kubba, Samir
    Neidhart, Jeffrey D.
    Tina, Maluso
    Swift, Regina
    Vescio, Robert
    BLOOD, 2017, 130
  • [46] Pomalidomide for multiple myeloma
    Douge, Aurore
    Lemal, Richard
    Chaleteix, Carine
    BULLETIN DU CANCER, 2017, 104 (09) : 707 - 713
  • [47] Pomalidomide in multiple myeloma
    Uccello, Giuseppina
    Petrungaro, Annamaria
    Mazzone, Carla
    Recchia, Anna Grazia
    Greco, Rosa
    Mendicino, Francesco
    Lucia, Eugenio
    Vigna, Ernesto
    Morabito, Fortunato
    Gentile, Massimo
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (02) : 133 - 137
  • [48] Pomalidomide for multiple myeloma
    Fouquet, G.
    Macro, M.
    Decaux, O.
    Fohrer, C.
    Guidez, S.
    Demarquette, H.
    Le Grand, C.
    Prodhomme, C.
    Renaud, L.
    Bories, C.
    Herbaux, C.
    Karlin, L.
    Roussel, M.
    Benboubker, L.
    Hulin, C.
    Arnulf, B.
    Leleu, X.
    REVUE DE MEDECINE INTERNE, 2015, 36 (09): : 613 - 618
  • [49] Pomalidomide for multiple myeloma
    Fouquet, Guillemette
    Bories, Claire
    Guidez, Stephanie
    Renaud, Loic
    Herbaux, Charles
    Javed, Sahir
    Facon, Thierry
    Leleu, Xavier
    EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (06) : 719 - 731
  • [50] Use of beta blockers is associated with survival outcome of multiple myeloma patients treated with pomalidomide
    Hwa, Yi L.
    Lacy, Martha Q.
    Gertz, Morie A.
    Kumar, Shaji K.
    Muchtar, Eli
    Buadi, Francis K.
    Dingli, David
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Hobbs, Miriam A.
    Fonder, Amie L.
    Gonsalves, Wilson I.
    Warsame, Rahma
    Kourelis, Taxiarchis V.
    Hayman, Susanne R.
    Siddiqui, Mustaqeem A.
    Rajkumar, S. Vincent
    Dispenzieri, Angela
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (03) : 433 - 436